ID

16365

Descripción

ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT00331097

Link

https://clinicaltrials.gov/show/NCT00331097

Palabras clave

  1. 12/7/16 12/7/16 -
Subido en

12 de julio de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00331097

Eligibility Breast Cancer NCT00331097

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed invasive unilateral breast cancer
Descripción

Invasive carcinoma of breast Unilateral

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0853879
UMLS CUI [1,2]
C0205092
age > 65 and < 80 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
intermediate-high risk of recurrence according to st. gallen criteria: er negative and pgr negative, or axillary lymph node metastasis, or tumor size > 2 cm, or tumor grade 2 or 3 (intermediate or high)
Descripción

Recurrence High risk Intermediate | Estrogen receptor negative | progesterone receptor negative | AXILLARY LYMPH NODE METASTASIS | Tumor size | TNM clinical staging

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2825055
UMLS CUI [1,2]
C0332167
UMLS CUI [1,3]
C3640764
UMLS CUI [2]
C0279756
UMLS CUI [3]
C0279766
UMLS CUI [4]
C0741344
UMLS CUI [5]
C0475440
UMLS CUI [6]
C3258246
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
performance status >1
Descripción

performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1518965
distant metastasis
Descripción

Distant metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1275402
concomitant malignancy or malignancy within previous 5 years (except basal cell or spinocellular skin cancer and in situ cervical cancer if they have been adequately treated
Descripción

Malignant Neoplasms | Basal cell carcinoma Treated Adequate | Spinocellular carcinoma Treated Adequate | Carcinoma in situ of uterine cervix Treated Adequate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0007117
UMLS CUI [2,2]
C1522326
UMLS CUI [2,3]
C0205411
UMLS CUI [3,1]
C1168311
UMLS CUI [3,2]
C1522326
UMLS CUI [3,3]
C0205411
UMLS CUI [4,1]
C0851140
UMLS CUI [4,2]
C1522326
UMLS CUI [4,3]
C0205411
previous breast cancer treatment
Descripción

Breast Cancer Therapeutic Procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1511300
neutrophils < 2000/mm3 or platelets < 100000/mm3 or haemoglobin < 10 g/dl
Descripción

Absolute neutrophil count | Blood Platelets | Hemoglobin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0005821
UMLS CUI [3]
C0019046
creatinine > 1.25 the upper normal limit
Descripción

Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
got and-or gpt and/or bilirubin > 1.25 the upper normal limit
Descripción

Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Serum total bilirubin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
UMLS CUI [3]
C1278039
concomitant conditions that contraindicate the use of the drugs in the protocol
Descripción

Medical contraindication Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0013230
incapacity or refusal to provide informed consent
Descripción

Informed Consent Unable | Informed Consent Refused

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C1705116

Similar models

Eligibility Breast Cancer NCT00331097

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Invasive carcinoma of breast Unilateral
Item
histologically confirmed invasive unilateral breast cancer
boolean
C0853879 (UMLS CUI [1,1])
C0205092 (UMLS CUI [1,2])
Age
Item
age > 65 and < 80 years
boolean
C0001779 (UMLS CUI [1])
Recurrence High risk Intermediate | Estrogen receptor negative | progesterone receptor negative | AXILLARY LYMPH NODE METASTASIS | Tumor size | TNM clinical staging
Item
intermediate-high risk of recurrence according to st. gallen criteria: er negative and pgr negative, or axillary lymph node metastasis, or tumor size > 2 cm, or tumor grade 2 or 3 (intermediate or high)
boolean
C2825055 (UMLS CUI [1,1])
C0332167 (UMLS CUI [1,2])
C3640764 (UMLS CUI [1,3])
C0279756 (UMLS CUI [2])
C0279766 (UMLS CUI [3])
C0741344 (UMLS CUI [4])
C0475440 (UMLS CUI [5])
C3258246 (UMLS CUI [6])
Item Group
C0680251 (UMLS CUI)
performance status
Item
performance status >1
boolean
C1518965 (UMLS CUI [1])
Distant metastasis
Item
distant metastasis
boolean
C1275402 (UMLS CUI [1])
Malignant Neoplasms | Basal cell carcinoma Treated Adequate | Spinocellular carcinoma Treated Adequate | Carcinoma in situ of uterine cervix Treated Adequate
Item
concomitant malignancy or malignancy within previous 5 years (except basal cell or spinocellular skin cancer and in situ cervical cancer if they have been adequately treated
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0205411 (UMLS CUI [2,3])
C1168311 (UMLS CUI [3,1])
C1522326 (UMLS CUI [3,2])
C0205411 (UMLS CUI [3,3])
C0851140 (UMLS CUI [4,1])
C1522326 (UMLS CUI [4,2])
C0205411 (UMLS CUI [4,3])
Breast Cancer Therapeutic Procedure
Item
previous breast cancer treatment
boolean
C1511300 (UMLS CUI [1])
Absolute neutrophil count | Blood Platelets | Hemoglobin
Item
neutrophils < 2000/mm3 or platelets < 100000/mm3 or haemoglobin < 10 g/dl
boolean
C0948762 (UMLS CUI [1])
C0005821 (UMLS CUI [2])
C0019046 (UMLS CUI [3])
Creatinine measurement, serum
Item
creatinine > 1.25 the upper normal limit
boolean
C0201976 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Serum total bilirubin measurement
Item
got and-or gpt and/or bilirubin > 1.25 the upper normal limit
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
Medical contraindication Investigational New Drugs
Item
concomitant conditions that contraindicate the use of the drugs in the protocol
boolean
C1301624 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Informed Consent Unable | Informed Consent Refused
Item
incapacity or refusal to provide informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C1705116 (UMLS CUI [2,2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial